Human Immunodeficiency Virus (HIV): Its Impact on the Immune System and Mechanisms of Immune Evasion

  Share :          
  223

Human Immunodeficiency Virus (HIV) is a retrovirus that primarily targets the human immune system, particularly CD4-positive T helper lymphocytes. This leads to a gradual weakening of immune responses and increases the body's susceptibility to infectious and opportunistic diseases. The major concern associated with this virus is its ability to persist within the human body and adapt to immune defense mechanisms, making it one of the most important subjects in virology and immunology research. HIV possesses a lipid envelope containing the surface glycoproteins gp120 and gp41, which are responsible for attachment to host cells and viral entry. Its genetic material consists of two copies of RNA, along with three essential enzymes: reverse transcriptase, integrase, and protease. These enzymes enable the virus to convert its RNA into DNA and integrate it into the host cell genome, allowing viral replication and long-term persistence within the body. Infection begins when the viral glycoprotein gp120 binds to the CD4 receptor and subsequently interacts with the co-receptors CCR5 or CXCR4, facilitating viral entry into the host cell. The viral RNA is then converted into DNA and integrated into the host cell's genetic material, initiating the production of new viral particles. Targeting CD4 cells disrupts immune system functions because these cells play a central role in coordinating immune responses and activating B and T lymphocytes. Consequently, a reduction in their numbers weakens the body's ability to fight infectious agents. One of the most important characteristics of HIV is its ability to evade the immune system through several mechanisms. These include a high mutation rate resulting from errors during reverse transcription, leading to changes in viral surface proteins and reducing their recognition by antibodies. Furthermore, HIV can establish latent viral reservoirs within certain immune cells, allowing it to persist for long periods without being effectively eliminated by the immune system. In addition, HIV produces viral proteins such as Nef, Vif, and Vpu, which interfere with cellular defense mechanisms. The Nef protein reduces the expression of MHC-I molecules on infected cell surfaces, weakening the ability of CD8+ cytotoxic T cells to recognize these cells. Meanwhile, Vif inhibits the antiviral factor APOBEC3G, while Vpu counteracts Tetherin, a protein that normally restricts the release of new viral particles from infected cells. HIV infection progresses through several stages, beginning with acute infection, followed by a chronic phase that may last for years. Without treatment, the infection can eventually progress to Acquired Immunodeficiency Syndrome (AIDS), in which the body becomes more vulnerable to opportunistic infections and certain cancers. Diagnosis relies on antigen and antibody tests, as well as molecular techniques such as RT-PCR. Viral load measurement and CD4 cell counts are also used to evaluate the patient's immune status. Although no definitive cure is currently available to completely eliminate HIV, antiretroviral therapy (ART) has significantly reduced viral replication, preserved immune system function, and improved the quality of life of infected individuals. Adherence to treatment is essential for controlling the infection and preventing sexual transmission when an undetectable viral load is achieved and maintained. Understanding HIV and its immune evasion mechanisms is of great importance in virology and molecular immunology, as it helps explain how the virus persists despite immune responses and provides a scientific foundation for developing future treatments targeting latent viral reservoirs and enhancing the immune system's ability to control the infection. Al-Mustaqbal University – The No. 1 University in Iraq